Arrowhead Pharmaceuticals Inc (FRA:HDP1)
€ 24.79 0.13 (0.53%) Market Cap: 3.07 Bil Enterprise Value: 2.91 Bil PE Ratio: 0 PB Ratio: 17.46 GF Score: 53/100

Arrowhead Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 03:15PM GMT
Release Date Price: €25.27 (-5.83%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Thank you, everyone. My name is Gena Wang. I'm SMID-cap biotech analyst at Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual health care conference possible.

With that, I would like to introduce our next speakers from Arrowhead. We have Bruce Given, Chief Operating Officer. We also have Vince Anzalone, VP, Head of Investor Relations. Bruce, I will hand over to you.

Bruce D. Given
Arrowhead Pharmaceuticals, Inc. - COO and Head of R&D

Good morning, everyone, and thank you for being here. We don't have much time, so let's just go right to the second slide, the classic forward-looking statement slide, just to remind any of you that would be considering investing that you can access all of our materials through the SEC website.

Next slide, please, Slide 3. So those of you who aren't familiar with us, our goal here is to treat

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot